Access & coverage resources
9 out of 10 patients have coverage with commercial insurance*
8 out of 10 eligible patients paid no more than $20 for their 30- or 90-day prescription of CAPLYTA
>99%
CAPLYTA is covered for eligible patients with Medicare Part D and Medicaid
Individual plans may vary. Please check respective plans for latest info.
- Source: Data on file, Intra-Cellular Therapies, Inc. Formulary data provided by Managed Markets Insight and Technology, LLC™, a trademark of MMIT, as of August 2025. Because formularies do change and many health plans offer more than one formulary, please check directly with the health plan to confirm coverage for individual patients.
- *Unrestricted access on the two largest PBMs- CVS Caremark & Express Scripts National Formulary.
